Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes ...
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial ...
Novavax shares jumped 50% on Monday following its recent licensing deal with Sanofi, as meme stocks are making a 2021-style ...
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
By Ben Glickman Shares of Novavax continued their ascent on Monday, adding to gains from last week after the company announced a licensing deal with ...
A Novavax shareholder that had been waging a campaign to oust three board members at the Gaithersburg company has now ...
Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the ...
(Rewrites throughout with details on the licensing deal and Novavax's earnings) PARIS, May 10 (Reuters) - Novavax on Friday erased doubts about its ability to remain in business and struck a licensing ...
Novavax ( NVAX -9.65%) has been a highly volatile stock in recent years, and that volatility is on full display again this ...
The vaccine maker's recovery story is looking brighter.
Aventis S.A. ADR (SNY-Q) from The Globe and Mail including charting and trades.
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination ...